Ultragenyx
RARE
$44.24
Share price
0.89%
Change (1 day)
4.19%
Change (1 year)
Categories
Ultragenyx (RARE) - Net assets
Net assets on the balance sheet as of December 2023 : $0.27 B
According to Ultragenyx's latest financial reports the company has $0.27 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Ultragenyx - Net assets on balance sheet (from 2012 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.27 B | -21.87% |
| 2022-12-31 | $0.35 B | -61.79% |
| 2021-12-31 | $0.92 B | -20.08% |
| 2020-12-31 | $1.15 B | 76.57% |
| 2019-12-31 | $0.65 B | 7.37% |
| 2018-12-31 | $0.60 B | 58.8% |
| 2017-12-31 | $0.38 B | -19.1% |
| 2016-12-31 | $0.47 B | -10.75% |
| 2015-12-31 | $0.53 B | 187.16% |
| 2014-12-31 | $0.18 B | 269.09% |
| 2013-12-31 | $50.1 M | -40.59% |
| 2012-12-31 | $84.34 M | 692.45% |
| 2011-12-31 | $10.64 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Lexicon Pharmaceuticals
LXRX | $0.13 B | -49.35% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | -$0.46 B | -265.20% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $0.16 B | -41.84% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $4.95 B | 1,697.86% | 🇺🇸 USA |